Skip to main content
. 2021 Jun 23;12(7):642. doi: 10.1038/s41419-021-03930-2

Fig. 5. DNMT1 and DNMT3a mediated 5-Aza-inhibited TXNIP expression in high glucose-treated RSC96 cells.

Fig. 5

A RNA-seq of DNMT1, DNMT3a, and DNMT3b in RSC96 cells treated with normal glucose and high glucose. B Western blot and statistical analysis of the effect of high glucose on DNMT1 and DNMT3a in RSC96 cells. *P < 0.05 versus N group. C Immunofluorescence of DNMT1 in RSC96 cells of normal glucose group (N) and high glucose group (H). Bar: 50 μm. D Immunofluorescence of DNMT3a in RSC96 cells of normal glucose group (N) and high glucose group (H). Bar: 50 μm. E Western blot and statistical analysis of the effect of DNMT1 and DNMT3a overexpression on TXNIP expression in RSC96 cells. *P < 0.05 versus pcDNA3.1 group. F Western blot and statistical analysis of the effect of DNMT1 and DNMT3a knockdown on TXNIP expression in RSC96 cells. *P < 0.05 versus pGenesil-1 group. G Confocal microscope observation of TXNIP expression in RSC96 cells successfully transfected with DNMT1 shRNA plasmid (pGenesil-1-DNMT1 expressing GFP tag). Oval showed those cells successfully transfected with pGenesil-1-DNMT1. Bar: 20 μm. H Confocal microscope observation of TXNIP expression in RSC96 cells successfully transfected with DNMT3a shRNA plasmid (pGenesil-1-DNMT3a expressing GFP tag). Round and oval showed those cells successfully transfected with pGenesil-1-DNMT3a. Bar: 20 μm. I Real-time PCR of TXNIP mRNA in high glucose-cultured RSC96 cells transfected with pGenesil-1, pGenesil-1-DNMT1, and pGenesil-1-DNMT3a. *P < 0.05 versus pGenesil-1 group. J Western blot and statistical analysis of the effect of MG132 and chloroquine on TXNIP expression in high glucose plus 5-Aza-treated RSC96 cells. *P < 0.05 versus 5-Aza treatment group. K Western blot and statistical analysis of the effect of MG132 and chloroquine on TXNIP expression in DNMT3a knockdown RSC96 cells. *P < 0.05 versus DMSO group.